News Sentiment

CGEN sentiment intelligence

Compugen news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 50 Balanced news tone 42 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.01 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

76/100 classification confidence.

Company focus 35

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-1.5% over one week, -28.2% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

Market Reaction

Balanced read

57/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 76/100 classification
One-week reaction -1.5% Price digesting
Trend fit Trend active -28.2% over four weeks
Fair value 15.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 32
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 35
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 9
simplywall.st 5
PR Newswire 3
TradingKey 3
MarketBeat 2
Quiver Quantitative 2
GuruFocus.com 1

Event Lens

What the news is about

Classified themes
Earnings 20
Market update 16
Analyst action 3
Guidance 1
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 42
Associated Press Direct company coverage

Compugen: Q1 Earnings Snapshot

Tone
Neutral 50/100
Event
Earnings
Published
18 May 2026 11:58
Source
Associated Press